project . 2020 - 2021 . On going

EXSCALATE4CoV

EXaSCale smArt pLatform Against paThogEns for Corona Virus
Open Access mandate for Publications European Commission
  • Funder: European CommissionProject code: 101003551 Call for proposal: H2020-SC1-PHE-CORONAVIRUS-2020
  • Funded under: H2020 | RIA Overall Budget: 2,970,880 EURFunder Contribution: 2,970,880 EUR
  • Status: On going
  • Start Date
    01 Apr 2020
    End Date
    30 Sep 2021
  • Detailed project information (CORDIS)
  • Open Access mandate
    Research Data: No
Description
The EXSCALATE4CoV (E4C) project aims to exploit the most powerful computing resources currently based in Europe to empower smart in-silico drug design. Advanced Computer-Aided Drug Design (CADD) in combination with the high throughput biochemical and phenotypic screening will allow the rapid evaluation of the simulations results and the reduction of time for the discovery of new drugs. Against a pandemic crisis, the immediate identification of effective treatments have a paramount importance. First, E4C will select through the EXSCALATE platform, the most promising commercialized and developing drugs safe in man. Second, select from >500 billion molecules new pa...
Description
The EXSCALATE4CoV (E4C) project aims to exploit the most powerful computing resources currently based in Europe to empower smart in-silico drug design. Advanced Computer-Aided Drug Design (CADD) in combination with the high throughput biochemical and phenotypic screening will allow the rapid evaluation of the simulations results and the reduction of time for the discovery of new drugs. Against a pandemic crisis, the immediate identification of effective treatments have a paramount importance. First, E4C will select through the EXSCALATE platform, the most promising commercialized and developing drugs safe in man. Second, select from >500 billion molecules new pa...
Any information missing or wrong?Report an Issue